Stockreport

Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium

Lineage Cell Therapeutics, Inc.  (LCTX) 
PDF Event Scheduled for June 26 and 27, 2024 CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechno [Read more]